{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:29:48Z","timestamp":1782311388463,"version":"3.54.5"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00338","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T13:40:10Z","timestamp":1582897210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders"],"prefix":"10.3389","volume":"11","author":[{"given":"Antonio","family":"Pecoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Varricchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders.","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2017.03.011","article-title":"Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels.","volume":"180","author":"Graziano","year":"2017","journal-title":"Clin Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update.","volume":"124","author":"Notarangelo","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12016-017-8645-0","article-title":"Review: diagnosing common variable immunodeficiency disorder in the era of genome sequencing.","volume":"54","author":"Ameratunga","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity.","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/cei.12947","article-title":"The role of genomics in common variable immunodeficiency disorders.","volume":"188","author":"Kienzler","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency.","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J Med Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency.","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaci.2019.02.017","article-title":"Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies.","volume":"144","author":"Blanco","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cellimm.2016.12.007","article-title":"Abnormality of regulatory T cells in common variable immunodeficiency.","volume":"315","author":"Azizi","year":"2017","journal-title":"Cell Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.4049\/jimmunol.1600526","article-title":"Accelerated loss of TCR repertoire diversity in common variable immunodeficiency.","volume":"197","author":"Wong","year":"2016","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.clim.2018.09.006","article-title":"Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications.","volume":"197","author":"Turpin","year":"2018","journal-title":"Clin Immunol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","article-title":"The T(H)1 phenotype of follicular helper T cells indicates an IFN-\u03b3-associated immune dysregulation in patients with CD21low common variable immunodeficiency.","volume":"141","author":"Unger","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12728","article-title":"Common variable immune deficiency: dissection of the variable.","volume":"287","author":"Cunningham-Rundles","year":"2019","journal-title":"Immunol Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaip.2013.09.015","article-title":"The variable in common variable immunodeficiency: a disease of complex phenotypes.","volume":"1","author":"Jolles","year":"2013","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency.","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.intimp.2017.09.005","article-title":"Immunoglobulin replacement therapy in primary and secondary antibody deficiency: the correct clinical approach.","volume":"52","author":"Pecoraro","year":"2017","journal-title":"Int Immunopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.intimp.2016.12.030","article-title":"Rapid infusions of human normal immunoglobulin 50g\/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.","volume":"44","author":"Spadaro","year":"2017","journal-title":"Int Immunopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0394632016681577","article-title":"Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies.","volume":"30","author":"Canessa","year":"2017","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2019.05.001","article-title":"Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients.","volume":"210","author":"Bagheri","year":"2019","journal-title":"Immunol Lett."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02546","article-title":"Gastric cancer is the leading cause of death in italian adult patients with common variable immunodeficiency.","volume":"9","author":"Pulvirenti","year":"2018","journal-title":"Front Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades.","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00895","article-title":"Total and high molecular Weight adiponectin expression is decreased in patients with common variable immunodeficiency: correlation with ig replacement therapy.","volume":"8","author":"Pecoraro","year":"2017","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2174\/1389201019666181010170630","article-title":"Gastroduodenal disorders in patients with CVID undergoing immunoglobulin therapy.","volume":"19","author":"Varricchi","year":"2018","journal-title":"Curr Pharm Biotechnol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10875-017-0461-z","article-title":"Chronic diarrhea in common variable immunodeficiency: a case series and review of the literature.","volume":"38","author":"Pecoraro","year":"2018","journal-title":"J Clin Immunol."},{"key":"B27","first-page":"2641","article-title":"Efficacy of subcutaneous immunoglobulins in primary immunodeficiency with Crohn\u2019s-like phenotype: report of a case.","volume":"19","author":"Sanges","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.iac.2018.08.006","article-title":"Gastrointestinal manifestations and complications of primary immunodeficiency disorders.","volume":"39","author":"Agarwal","year":"2019","journal-title":"Immunol Allergy Clin North Am."},{"key":"B29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia.","volume":"20","author":"Washington","year":"1996","journal-title":"Am J Surg Pathol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease.","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/ajg.2016.329","article-title":"Cross-Sectional Study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency.","volume":"111","author":"J\u00f8rgensen","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-018-0574-z","article-title":"Autoimmunity and inflammation in CVID: a possible crosstalk between immune activation, gut microbiota, and epigenetic modifications.","volume":"39","author":"J\u00f8rgensen","year":"2019","journal-title":"J Clin Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12016-017-8638-z","article-title":"Common variable immunodeficiency and liver involvement.","volume":"55","author":"Song","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2249.2008.03711.x","article-title":"Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.","volume":"153","author":"Ward","year":"2008","journal-title":"Clin Exp Immunol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.jaip.2019.04.016","article-title":"Liver disease is common in patients with common variable immunodeficiency and predicts mortality in the presence of cirrhosis or portal hypertension.","volume":"7","author":"Azzu","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients.","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets.","volume":"8","author":"Farmer","year":"2018","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/PAS.0000000000000661","article-title":"Spleen histologic appearance in common variable immunodeficiency: analysis of 17 cases.","volume":"40","author":"Furudo\u00ef","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.dld.2019.05.016","article-title":"Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency.","volume":"51","author":"Crescenzi","year":"2019","journal-title":"Dig Liver Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hep.21258","article-title":"Nodular regenerative hyperplasia: not all nodules are created equal.","volume":"44","author":"Reshamwala","year":"2006","journal-title":"Hepatology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/MEG.0b013e3283360021","article-title":"Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series.","volume":"22","author":"Morris","year":"2010","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cld.2010.07.009","article-title":"Sinusoidal obstruction syndrome.","volume":"14","author":"Rubbia-Brandt","year":"2010","journal-title":"Clin Liver Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3748\/wjg.v17.i11.1400","article-title":"Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.","volume":"17","author":"Hartleb","year":"2011","journal-title":"World J Gastroenterol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MEG.0b013e328334098f","article-title":"Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.","volume":"22","author":"Laharie","year":"2010","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/2050640616680550","article-title":"Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all dutch liver transplant units.","volume":"5","author":"Meijer","year":"2017","journal-title":"United European Gastroenterol J."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120299","article-title":"NRH-Pathology investigators. diagnosing nodular regenerative hyperplasia of the liver is thwarted by low interobserver agreement.","volume":"10","author":"Jharap","year":"2015","journal-title":"PLoS One."},{"key":"B48","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology."},{"key":"B49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0676.1989.tb00409.x","article-title":"Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases.","volume":"9","author":"Colina","year":"1989","journal-title":"Liver."},{"key":"B50","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency.","volume":"33","author":"Fuss","year":"2013","journal-title":"J Clin Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jhep.2007.08.011","article-title":"Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.","volume":"48","author":"Malamut","year":"2008","journal-title":"J Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis.","volume":"63","year":"2015","journal-title":"J Hepatol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/672458","article-title":"Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.","volume":"2014","author":"Pulvirenti","year":"2014","journal-title":"J Immunol Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4049\/jimmunol.1800102","article-title":"Neutrophil and granulocytic myeloid-derived suppressor cell-mediated t cell suppression significantly contributes to immune dysregulation in common variable immunodeficiency disorders.","volume":"202","author":"Vlkova","year":"2019","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.humpath.2008.09.008","article-title":"Hepatitis in common variable immunodeficiency.","volume":"40","author":"Daniels","year":"2009","journal-title":"Hum Pathol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2249.2012.04620.x","article-title":"Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels.","volume":"169","author":"Barbosa","year":"2012","journal-title":"Clin Exp Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s10875-014-0099-z","article-title":"Altered serum cytokine signature in common variable immunodeficiency.","volume":"34","author":"Hel","year":"2014","journal-title":"J Clin Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1084\/jem.20140039","article-title":"Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.","volume":"211","author":"Perreau","year":"2014","journal-title":"J Exp Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2249.2012.04655.x","article-title":"Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia.","volume":"170","author":"Litzman","year":"2012","journal-title":"Clin Exp Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/mi.2016.18","article-title":"Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.","volume":"9","author":"J\u00f8rgensen","year":"2016","journal-title":"Mucosal Immunol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2049","article-title":"Viral infection in primary antibody deficiency syndromes.","volume":"29","author":"Jones","year":"2019","journal-title":"Rev Med Virol."},{"key":"B63","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.","volume":"331","author":"Bj\u00f8ro","year":"1994","journal-title":"N Engl J Med."},{"key":"B64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/clim.2001.5132","article-title":"Cunningham\u2212rundles C. outcome of intravenous immunoglobulin\u2212transmitted hepatitis C virus infection in primary immunodeficiency.","volume":"101","author":"Razvi","year":"2001","journal-title":"Clin Immunol."},{"key":"B65","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/clim.2001.5036","article-title":"Five\u2212year followup of patients with primary antibody deficiencies following an outbreak of acute hepatitis C.","volume":"99","author":"Chapel","year":"2001","journal-title":"Clin Immunol."},{"key":"B66","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0168-8278(97)80133-X","article-title":"Hcv and hypogammaglobulinemia.","volume":"26","author":"Sierra","year":"1997","journal-title":"J Hepatol."},{"key":"B67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2249.1995.tb06629.x","article-title":"Hcv infection in patients with primary defects of immunoglobulin production.","volume":"102","author":"Quinti","year":"1995","journal-title":"Clin Exp Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunedeficiency disorders: division into distinct clinical phenotypes.","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaip.2016.03.021","article-title":"Comprehensive approach to the management of children and adults with chronic granulomatous disease.","volume":"4","author":"Thomsen","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-016-0491-3","article-title":"Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD).","volume":"18","author":"Uzzan","year":"2016","journal-title":"Curr Gastroenterol Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2169\/internalmedicine.56.7305","article-title":"Diffuse nodular lymphoid hyperplasia of the intestine caused by common variable immunodeficiency and refractory giardiasis.","volume":"56","author":"Choi","year":"2017","journal-title":"Intern Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study.","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood."},{"key":"B74","first-page":"133","article-title":"Malignancy phenotype in common variable immunodeficiency.","volume":"22","author":"Abolhassani","year":"2012","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2014.10.003","article-title":"Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy.","volume":"156","author":"Jonkman-Berk","year":"2015","journal-title":"Clin Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.aller.2017.01.006","article-title":"Epidemiology and pathophysiology of malignancy in common variable immunodeficiency?","volume":"45","author":"Tak Manesh","year":"2017","journal-title":"Allergol Immunopathol (Madr)."},{"key":"B77","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2012-05-431064","article-title":"Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency.","volume":"120","author":"Quinti","year":"2012","journal-title":"Blood."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry.","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders.","volume":"141","author":"Hauck","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1393134","article-title":"Eosinophils: the unsung heroes in cancer?","volume":"7","author":"Varricchi","year":"2017","journal-title":"Oncoimmunology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/JLB.3MR0717-292R","article-title":"Roles of neutrophils in cancer growth and progression.","volume":"103","author":"Galdiero","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.leukres.2015.02.002","article-title":"Lymphoproliferative disease and cancer among patients with common variable immunodeficiency.","volume":"39","author":"Gangemi","year":"2015","journal-title":"Leuk Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10875-011-9565-z","article-title":"Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events.","volume":"31","author":"da Silva","year":"2011","journal-title":"J Clin Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.3748\/wjg.v21.i41.11489","article-title":"Italian Research Group for Gastric Cancer. Hepatic metastases from gastric cancer: A surgical perspective.","volume":"21","author":"Tiberio","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0820-4","article-title":"Updates on management of gastric cancer.","volume":"21","author":"Johnston","year":"2019","journal-title":"Curr Oncol Rep."},{"key":"B86","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat Immunol."},{"key":"B87","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clim.2004.07.002","article-title":"deficiency in patients with common variable immunodeficiency.","volume":"113","author":"Salzer","year":"2004","journal-title":"Clin Immunol."},{"key":"B88","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaci.2014.12.1940","article-title":"A novel mutation in ICOS presenting as hypogammaglobulinemia with susceptibility to opportunistic pathogens.","volume":"136","author":"Chou","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.4049\/jimmunol.0803256","article-title":"Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10875-015-0193-x","article-title":"Astute clinician report: a novel 10 bp frameshift deletion in exon 2 of ICOS causes a combined immunodeficiency associated with an enteritis and hepatitis.","volume":"35","author":"Robertson","year":"2015","journal-title":"J Clin Immunol."},{"key":"B91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00964","article-title":"14 years after discovery: clinical follow-up on 15 patients with inducible co-stimulator deficiency.","volume":"8","author":"Schepp","year":"2017","journal-title":"Front Immunol."},{"key":"B92","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2016.05.045","article-title":"Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1-mutated common variable immunodeficiency disease.","volume":"139","author":"Lougaris","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2016.10.054","article-title":"Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.","volume":"140","author":"Kaustio","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B94","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.3324\/haematol.2016.145136","article-title":"Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans.","volume":"101","author":"Schipp","year":"2016","journal-title":"Haematologica."},{"key":"B95","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"NIHR bioresource\u2013rare diseases consortium. Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B96","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.cdd.4401870","article-title":"Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice.","volume":"13","author":"Pasparakis","year":"2006","journal-title":"Cell Death Differ."},{"key":"B97","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10875-016-0306-1","article-title":"-\u03baB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation.","volume":"36","author":"Boztug","year":"2016","journal-title":"J Clin Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-\u03baB1 subunit p50 in common variable immunodeficiency.","volume":"97","author":"Fliegauf","year":"2015","journal-title":"Am J Hum Genet."},{"key":"B99","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","article-title":"Germline mutations in NFKB2 implicate the noncanonical NF-\u03baB pathway in the pathogenesis of common variable immunodeficiency.","volume":"93","author":"Chen","year":"2013","journal-title":"Am J Hum Genet."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00297","article-title":"Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2.","volume":"10","author":"Klemann","year":"2019","journal-title":"Front Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.","volume":"11","author":"Walker","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2174\/0929867324666170407125017","article-title":"Immune checkpoint inhibitors and cardiac toxicity: an emerging issue.","volume":"25","author":"Varricchi","year":"2018","journal-title":"Curr Med Chem."},{"key":"B103","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.","volume":"349","author":"Lo","year":"2015","journal-title":"Science."},{"key":"B107","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s10875-019-00677-6","article-title":"A spectrum of clinical findings from ALPS to CVID: several Novel LRBA defects.","volume":"39","author":"Cagdas","year":"2019","journal-title":"J Clin Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MIB.0000000000000266","article-title":"Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype.","volume":"21","author":"Serwas","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of phenotypes associated with mutations in LRBA.","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J Clin Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency.","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.","volume":"211","author":"Lucas","year":"2014","journal-title":"J Exp Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.tranon.2018.11.003","article-title":"Hamartoma tumor syndrome and immune dysregulation.","volume":"12","author":"Eissing","year":"2019","journal-title":"Transl Oncol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage.","volume":"342","author":"Angulo","year":"2013","journal-title":"Science."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","article-title":"PI3K pathway defects leading to immunodeficiency and immune dysregulation.","volume":"143","author":"Nunes-Santos","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2018.01.005","article-title":"Liver disturbances in activated phosphoinositide 3-kinase \u03b4 syndrome.","volume":"6","author":"Ben-Yakov","year":"2018","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B117","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study.","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10875-014-0109-1","article-title":"Gain of function mutations of PIK3CD as a cause of primary sclerosing cholangitis.","volume":"35","author":"Hartman","year":"2015","journal-title":"J Clin Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment.","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2.","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med."},{"key":"B122","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3899\/jrheum.150024","article-title":"Case Series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations.","volume":"42","author":"Batu","year":"2015","journal-title":"J Rheumatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/MOP.0000000000000160","article-title":"Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodeficiency.","volume":"26","author":"Kotlarz","year":"2014","journal-title":"Curr Opin Pediatr."},{"key":"B124","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1084\/jem.20111229","article-title":"Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome.","volume":"210","author":"Kotlarz","year":"2013","journal-title":"J Exp Med."},{"key":"B125","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.3324\/haematol.2014.120980","article-title":"Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R.","volume":"100","author":"Erman","year":"2015","journal-title":"Haematologica."},{"key":"B126","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.3324\/haematol.2014.112508","article-title":"Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency.","volume":"100","author":"Stepensky","year":"2015","journal-title":"Haematologica."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1500673","article-title":"IL-21 receptor signaling is essential for control of hepatocellular carcinoma growth and immunological memory for tumor challenge.","volume":"7","author":"Zheng","year":"2018","journal-title":"Oncoimmunology."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-019-0113-3","article-title":"Immunosuppressive therapy with rituximab in common variable immunodeficiency.","volume":"17","author":"Pecoraro","year":"2019","journal-title":"Clin Mol Allergy."},{"key":"B129","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut."},{"key":"B130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology."},{"key":"B131","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00428-015-1862-0","article-title":"Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder.","volume":"467","author":"Szablewski","year":"2015","journal-title":"Virchows Arch."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1053\/j.gastro.2017.03.016","article-title":"American gastroenterological association institute technical review on the role of elastography in chronic liver diseases.","volume":"152","author":"Singh","year":"2017","journal-title":"Gastroenterology."},{"key":"B133","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","year":"2015","journal-title":"J Hepatol."},{"key":"B134","first-page":"IV1","article-title":"Guidelines on the use of liver biopsy in clinical practice. British society of gastroenterology.","author":"Grant","year":"1999","journal-title":"Gut."},{"key":"B135","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/j.gastro.2014.08.045","article-title":"Challenges to liver transplantation and strategies to improve outcomes.","volume":"148","author":"Dutkowski","year":"2015","journal-title":"Gastroenterology."},{"key":"B136","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL Clinical practice guidelines: liver transplantation.","volume":"64","year":"2016","journal-title":"J Hepatol."},{"key":"B137","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jaci.2016.10.025","article-title":"Liver transplantation in patients with primary antibody deficiency.","volume":"139","author":"J\u00f8rgensen","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/lt.24979","article-title":"Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome.","volume":"24","author":"Azzu","year":"2018","journal-title":"Liver Transpl."},{"key":"B139","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/lt.25343","article-title":"Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome.","volume":"24","author":"Ramlaul","year":"2018","journal-title":"Liver Transpl."},{"key":"B140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.dld.2014.03.002","article-title":"De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency.","volume":"46","author":"Aguilera","year":"2014","journal-title":"Dig Liver Dis."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226095","article-title":"Successful liver transplantation in common variable immune deficiency with reversal of hepatopulmonary syndrome.","volume":"12","author":"Apostolov","year":"2019","journal-title":"BMJ Case Rep."},{"key":"B142","doi-asserted-by":"publisher","first-page":"541","DOI":"10.12659\/AOT.890952","article-title":"Liver transplantation in patients with common variable immunodeficiency: a report of two cases.","volume":"19","author":"Montalti","year":"2014","journal-title":"Ann Transplant."},{"key":"B143","doi-asserted-by":"publisher","first-page":"E210","DOI":"10.1111\/j.1399-3046.2011.01545.x","article-title":"Liver transplantation for severe hepatitis in patients with common variable immunodeficiency.","volume":"16","author":"Murakawa","year":"2012","journal-title":"Pediatr Transplant."},{"key":"B144","first-page":"1787","article-title":"Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver.","volume":"45","author":"Loinaz","year":"1998","journal-title":"Hepatogastroenterology."},{"key":"B145","doi-asserted-by":"publisher","first-page":".e1","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency.","volume":"135","author":"Wehr","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00694","article-title":"Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of australian adults.","volume":"9","author":"Slade","year":"2018","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00338\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T13:40:23Z","timestamp":1582897223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00338\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":147,"alternative-id":["10.3389\/fimmu.2020.00338"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00338","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"article-number":"338"}}